Search Results for keywords:"National Heart Lung and Blood Institute"

The National Heart, Lung, and Blood Institute announced a closed meeting of the Board of Scientific Counselors scheduled for February 1, 2021. The purpose of the meeting is to review and evaluate the qualifications and performance of personnel and individual investigators within the institute. This virtual meeting will be closed to the public to protect personal privacy. Details and the agenda will be available on the NHLBI's website, and interested members of the public can submit written comments to the listed contact person.

The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, announced a closed meeting for the Heart, Lung, and Blood Initial Review Group. This virtual meeting, scheduled for April 16-17, 2025, will focus on reviewing and evaluating grant applications. The meeting is closed to the public as it will discuss sensitive information, including trade secrets and personal data. For more details, interested parties can contact Dr. Kazuyo Kegan, the Scientific Review Officer.

The National Heart, Lung, and Blood Institute announced a closed meeting for its NHLBI Mentored Patient-Oriented Research Review Committee. The meeting is scheduled to take place virtually from March 4 to March 5, 2021, between 10:00 a.m. and 6:00 p.m. This session will focus on reviewing and evaluating grant applications. The meeting will be closed to the public to protect confidential information, including trade secrets and personal details related to the grant applications.

The National Heart, Lung, and Blood Institute announced a closed meeting for the Heart, Lung, and Blood Initial Review Group, specifically the Clinical Trials Review Committee, to be held virtually on February 25-26, 2021. The purpose of the meeting is to review and evaluate grant applications. The meeting is closed to the public in accordance with the law to protect confidential information and personal privacy. Keary A. Cope, Ph.D., will serve as the contact person for the meeting.

The National Heart, Lung, and Blood Institute, part of the National Institutes of Health, has announced a closed meeting for the Heart, Lung, and Blood Initial Review Group to discuss grant applications. This virtual meeting, scheduled for February 20-21, 2025, from 9:00 a.m. to 12:00 p.m., will review applications that may involve confidential information, including trade secrets or personal data. Because of this sensitive content, the meeting will not be open to the public. For more information, Fungai Chanetsa, the Scientific Review Officer, can be contacted at the provided details.

The National Heart, Lung, and Blood Institute has announced a closed meeting of the Heart, Lung, and Blood Initial Review Group, specifically the Program Project Study Section. This meeting, scheduled for April 28-29, 2025, will take place virtually and will be closed to the public due to the sensitive nature of the topics to be discussed, including confidential trade secrets and personal information in grant applications. The agenda of the meeting is to review and evaluate these grant applications.